Bioz and Bioss Antibodies Launch Collaboration to Provide Real-Time Citation Data

Bioz, Inc., a leading AI software company based in Silicon Valley, has announced a collaboration with Bioss Antibodies, a prominent player in antibody development and manufacturing. Bioss Antibodies, known for its extensive catalog of over 12,000 primary antibodies and more than 300,000 derived products, has been crucial in advancing scientific research for over a decade.

Through this collaboration, Bioss Antibodies will integrate Bioz Badges on their product web pages. These AI-powered citation widgets display real-time article citation data, including excerpts and images from peer-reviewed publications, live citation counts, and Bioz Stars ratings. This initiative aims to help researchers make informed decisions by providing up-to-date application data directly on product pages.

"We are very excited about the integration of Bioz Badges onto our product webpages," said David Mello, Marketing Manager at Bioss. "Displaying citation data supports researchers in their purchasing process, and our Bioz Badges promise to do this efficiently and dynamically."

Dr. Karin Lachmi, Co-founder and CRO of Bioz, stated, "Selecting the right antibody is crucial for research success. We are thrilled to support Bioss' researchers in gaining necessary validation. Working with the Bioss team has been a pleasure, and we look forward to the continued benefits for researchers."